683 Capital Management »

Camp4 Therapeutics Corp shares owned by 683 Capital Management

Quarter-by-quarter ownership of Camp4 Therapeutics Corp (CAMP) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Camp4 Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Camp4 Therapeutics Corp held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Camp4 Therapeutics Corp by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $775k 126k 6.13

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Camp4 Therapeutics Corp

5AM Venture Management
Henderson Group
Vivo Capital
Enavate Sciences GP
FMR
AH Capital Management
Adage Capital Partners GP
Vanguard Group
HarbourVest Partners
BlackRock
Geode Capital Management
EcoR1 Capital
Stonepine Capital Management
Alyeska Investment Group
683 Capital Management

View all funds holding Camp4 Therapeutics Corp